Real-World Evidence | FDA
The .gov means it’s official.Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. FDA has a long history of using what we currently call real-world data (RWD) and real-world evidence (RWE) to monitor and evaluate the postmarket safety of approved drugs. RWE has also been used historically to support effectiveness, but on a more limited basis. Advances in the availability and analysis of RWD have increased the potential for generating robust RWE to support FDA regulatory decisions. FDA is committed to realizing the full potential of fit-for-purpose RWD to generate RWE that will advance the development of therapeutic products and strengthen regulatory oversight of medical products across their lifecycle. Real-world data are data relating to
FDA has a long history of using what we currently call real-world data (RWD) and real-world evidence (RWE) to monitor and evaluate the postmarket safety of approved drugs. RWE has also been used historically to support effectiveness, but on a more limited basis. Advances in the availability and analysis of RWD have increased the potential for generating robust RWE to support FDA regulatory decisions. FDA is committed to realizing the full potential of fit-for-purpose RWD to generate RWE that will advance the development of therapeutic products and strengthen regulatory oversight of medical pro
Explore this link on the map →related reading
- "How are the Best Companies using RWE to Accelerate Drug Development?"linkedin.com
- FDA Announces Major Steps to Implement Real-Time Clinical Trials | FDAfda.gov
- Biotech’s Lost Archive | IFPifp.org
- Checking your browser - reCAPTCHAncbi.nlm.nih.gov
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- Biotech’s Lost Archive | IFPifp.org
- Federal Register :: Platform Technology Designation Program; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Requestfederalregister.gov
- Why the FDA Is Slow to Remove Drugspress.asimov.com
- Life sciences | Deloitte Insightswww2.deloitte.com
- Patient Registries - Registries for Evaluating Patient Outcomes - NCBI Bookshelfncbi.nlm.nih.gov
- Checking your browser - reCAPTCHAncbi.nlm.nih.gov
- The 23andMe Deal - Cremieux Recueilcremieux.xyz